Press release
Dementia Associated with Alzheimer's Disease Market to Surpass [US$ 9.3 Billion] by 2031, Driven by Innovation in Drug Development and Early Diagnosis - TMR Study
Dementia Associated with Alzheimer's Disease
The global dementia associated with Alzheimer's disease market was valued at US$ 6.2 billion in 2022. It is projected to expand at a CAGR of 4.6% from 2023 to 2031, reaching US$ 9.3 billion by the end of the forecast period. The growing burden of neurodegenerative diseases and the increasing focus on research and development are contributing to market expansion.
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39203
Analyst Viewpoint
Market analysts anticipate steady growth in the dementia associated with Alzheimer's disease market due to the rising number of patients, ongoing clinical trials, and government initiatives to enhance treatment accessibility. However, challenges such as high treatment costs, limited availability of disease-modifying therapies, and regulatory hurdles may impact market dynamics.
Market Demand and Key Drivers
Growing Geriatric Population: With a rise in the elderly population, the prevalence of Alzheimer's disease is increasing, driving market demand.
Advancements in Drug Development: Pharmaceutical companies are investing in research to develop novel therapeutics, including disease-modifying drugs.
Government and Private Sector Initiatives: Increased funding for Alzheimer's research and awareness programs is supporting market growth.
Rising Demand for Personalized Medicine: Precision medicine and biomarker-based therapies are gaining traction for better disease management.
Technological Innovations in Diagnosis: Advancements in imaging techniques and biomarker-based diagnostics are improving early detection rates.
Expansion of Home Care and Assisted Living Services: The growing demand for home-based and assisted care facilities is boosting market expansion.
Recent Developments
2022, Biogen & Eisai: Received FDA approval for an anti-amyloid Alzheimer's drug.
2023, Roche: Announced progress in its late-stage clinical trials for Alzheimer's treatment.
2023, Eli Lilly: Reported promising results from its disease-modifying therapy candidate.
2024, Novartis: Invested in AI-driven drug discovery for Alzheimer's therapies.
2024, Johnson & Johnson: Partnered with biotech firms to accelerate Alzheimer's drug development.
Key Market Players
Merz Pharma
Novartis AG
AbbVie Inc.
Pfizer, Inc.
Daiichi Sankyo Company, Limited.
Ono Pharmaceutical Co., Ltd.
Johnson & Johnson Services, Inc.
Eisai Co., Ltd.
H. Lundbeck A/S
F. Hoffmann-La Roche Ltd.,
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39203
Market Trends and Opportunities
Development of Disease-Modifying Therapies: Efforts to introduce therapies that slow disease progression rather than just treating symptoms.
Rise in Digital Therapeutics: Use of AI-based cognitive training and digital interventions.
Collaborations Between Pharma and Biotech Firms: Partnerships to accelerate drug discovery and regulatory approvals.
Expansion of Early Diagnosis Programs: Efforts to detect Alzheimer's at an earlier stage to enhance treatment outcomes.
Regulatory Approvals for New Therapies: Ongoing clinical trials and fast-track approvals are shaping the market landscape.
Market Segmentation
By Drug Type:
Cholinesterase Inhibitors
NMDA Receptor Antagonists
Combination Therapy
Other Drug Classes
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By End-User:
Hospitals
Specialty Clinics
Homecare Settings
Regional Analysis
North America: Strong market presence due to high healthcare expenditure and advanced research infrastructure.
Europe: Government-backed Alzheimer's research programs are driving regional growth.
Asia-Pacific: Rising healthcare access and an aging population are key growth factors.
Latin America & Middle East/Africa: Increasing awareness and healthcare investments are supporting market expansion.
Future Market Analysis
The future of the dementia associated with Alzheimer's disease market is promising, with continued innovations in drug discovery, increasing adoption of digital health solutions, and expanding clinical trials for disease-modifying treatments. Companies investing in precision medicine and biomarker-based diagnostics will gain a competitive edge. Regulatory support and enhanced patient care strategies will further drive market growth.
Explore Latest Research Reports by Transparency Market Research:
Healthcare Biometrics Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-biometrics-market-to-surpass-us-7408-billion-by-2035-driven-by-advancements-in-security-digital-health-solutions-tmr-insights
Healthcare Contract Research Outsourcing Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-contract-research-outsourcing-market-to-surpass-us-6309-billion-by-2035-driven-by-increasing-demand-for-cost-effective-drug-development
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dementia Associated with Alzheimer's Disease Market to Surpass [US$ 9.3 Billion] by 2031, Driven by Innovation in Drug Development and Early Diagnosis - TMR Study here
News-ID: 3940951 • Views: …
More Releases from Transparency Market Research
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035.
Gain a preview of important insights from…
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035.
Access key findings…
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)…
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035.
Access key…
More Releases for Alzheimer
Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment …
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928
Key Takeaways
• Disease-modifying…
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
